Health Technology Assessment (HTA) at ang paglilista ng mga gamot sa Philippine National Formulary (PNF) Nilikha ang Health Technology Assessment Council (HTAC) sa ilalim ng Universal Healthcare Act of 2019 (Republic Act No. 11223) upang masiguro na abot-kaya para sa lahat ang serbisyong pangkalusugan sa bawat Pilipino. Nagbibigay ng teknikal na gabay ang HTAC sa continue reading : Gabay ng HTAC: Pagsama ng Oral PrEP sa PNF
HTAC GUIDANCE: Oral PrEP for inclusion in the PNF
Health Technology Assessment (HTA) and the inclusion of Drugs in the Philippine National Formulary (PNF) The Health Technology Assessment Council (HTAC) was created under the Universal Healthcare Act of 2019 (Republic Act No. 11223) to ensure equitable access to quality and affordable health care to Filipinos. The HTAC provides technical guidance on the optimal use of health technologies including drugs that are for continue reading : HTAC GUIDANCE: Oral PrEP for inclusion in the PNF
Emtricitabine + Tenofovir Disoproxil Fumarate Fixed-Dose Combination as Oral Pre-Exposure Prophylaxis (PrEP) to Reduce the Risk of Sexually Acquired HIV-Infection
Date of publication: December 17, 2021 Decision of the Secretary of Health: Approved (18 January 2022) Evidence Summary: Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP) to reduce the risk of sexually acquired HIV infection Advisory for Appeals on Preliminary Recommendation: https://bit.ly/PrelimES-OralPrEP-Dec21 HTAC Recommendation Review: